NATH BIOGENES (INDIA)
Back to Income Statement
|
NATH BIOGENES (INDIA) Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹20.31 | ₹20.85 | ₹18.43 | ₹-35.46 | ₹7.34 |
What is the latest Earnings Per Share (EPS) of NATH BIOGENES (INDIA) ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹20.31 |
| Mar2024 | ₹20.85 |
| Mar2023 | ₹18.43 |
| Mar2022 | ₹-35.46 |
| Mar2013 | ₹7.34 |
How is Earnings Per Share (EPS) of NATH BIOGENES (INDIA) Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹20.31 | -2.59 | |
| Mar2024 | ₹20.85 | 13.13 | |
| Mar2023 | ₹18.43 | Positive | |
| Mar2022 | ₹-35.46 | Negative | |
| Mar2013 | ₹7.34 | - | |
Compare Earnings Per Share (EPS) of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹246.3 Cr | -7.4% | -13.6% | -9.4% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹9,596.4 Cr | -8.5% | -22.1% | -20.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,071.2 Cr | -2.7% | -1.2% | -36.3% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,710.9 Cr | -6.9% | -11.2% | -24.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹707.0 Cr | -14.1% | -25.9% | -41.4% | Stock Analytics | |
| INDO US BIOTECH | ₹200.7 Cr | -4.8% | -30.6% | -34.8% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -7.4% |
-13.6% |
-9.4% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses